QUYNH MAI: Open Payments
NPI 1982668190 · KENNER, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,196 in 178 payments from 22 companies in 2025. Trend: 2023 $3,119 · 2024 $3,321 · 2025 $3,196
Food & beverage: $3,196
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $589 |
| GlaxoSmithKline, LLC. | 21 | $409 |
| AstraZeneca Pharmaceuticals LP | 13 | $315 |
| PFIZER INC. | 15 | $291 |
| Axsome Therapeutics, Inc. | 13 | $241 |
| Ardelyx, Inc. | 7 | $200 |
| Bayer Healthcare Pharmaceuticals Inc. | 13 | $173 |
| Lilly USA, LLC | 10 | $159 |
| Astellas Pharma US Inc | 8 | $153 |
| Esperion Therapeutics, Inc. | 9 | $153 |
Products named: TRELEGY ELLIPTA, VRAYLAR, ELIQUIS, Auvelity, IBSRELA, FARXIGA, Kerendia, Veozah.
Industry payments across LA — which companies pay providers there.
